This inventor holds 1 USPTO granted patent and 6 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Centaurus Therapeutics. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jeremy Blitzer: Innovator in Dihydroceramide Desaturase Inhibition
Introduction
Jeremy Blitzer is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic compounds. His work focuses on innovative solutions for treating metabolic disorders.
Latest Patents
Jeremy Blitzer holds a patent for "Inhibitors of dihydroceramide desaturase for treating disease." This patent discloses dihydroceramide desaturase 1 (Des1) inhibitor compounds and compositions. These compounds are useful in the treatment of diseases where inhibition of Des1 is expected to be therapeutic. The patent also provides methods for inhibiting Des1 activity in human or animal subjects.
Career Highlights
Jeremy is currently associated with Centaurus Therapeutics, where he applies his expertise in biochemistry to develop innovative treatments. His work has the potential to impact the lives of patients suffering from metabolic disorders.
Collaborations
Jeremy collaborates with various professionals in his field, including his coworker, Donna Lee Romero. Their combined efforts contribute to advancing research and development in therapeutic solutions.
Conclusion
Jeremy Blitzer is a dedicated inventor whose work in dihydroceramide desaturase inhibition showcases his commitment to improving health outcomes. His innovative approach and collaboration with others in the field highlight the importance of teamwork in scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile